Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

REGENERON PHARMACEUTICALS, INC.

Filed by THE WASHINGTON TAX & PUBLIC POLICY GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2025
Income
$30,000.00
Expenses
Not reported
Filing UUID
39d67d93-afb4-4fd4-9097-e8cf0169e27f
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

TAX · Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), 174 and 41. (H.R. 1990)

Literal federal measure citations: H.R. 1990

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.